These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19627112)

  • 41. Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product.
    Massiah MA; Saraswat V; Azurmendi HF; Mildvan AS
    Biochemistry; 2003 Sep; 42(34):10140-54. PubMed ID: 12939141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site.
    Groche D; Becker A; Schlichting I; Kabsch W; Schultz S; Wagner AF
    Biochem Biophys Res Commun; 1998 May; 246(2):342-6. PubMed ID: 9610360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
    Totoritis R; Duraiswami C; Taylor AN; Kerrigan JJ; Campobasso N; Smith KJ; Ward P; King BW; Murrayz-Thompson M; Jones AD; Van Aller GS; Aubart KM; Zalacain M; Thrall SH; Meek TD; Schwartz B
    Biochemistry; 2011 Aug; 50(31):6642-54. PubMed ID: 21711014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A high quality nuclear magnetic resonance solution structure of peptide deformylase from Escherichia coli: application of an automated assignment strategy using GARANT.
    O'Connell JF; Pryor KD; Grant SK; Leiting B
    J Biomol NMR; 1999 Apr; 13(4):311-24. PubMed ID: 10353194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
    Gupta MK; Mishra P; Prathipati P; Saxena AK
    Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periplasmic loop P2 of the MalF subunit of the maltose ATP binding cassette transporter is sufficient to bind the maltose binding protein MalE.
    Jacso T; Grote M; Daus ML; Schmieder P; Keller S; Schneider E; Reif B
    Biochemistry; 2009 Mar; 48(10):2216-25. PubMed ID: 19159328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of the binding modes between BB-83698 and peptide deformylase from Bacillus stearothermophilus by docking and molecular dynamics simulation.
    Wang Q; Wang J; Cai Z; Xu W
    Biophys Chem; 2008 May; 134(3):178-84. PubMed ID: 18321635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis for ligand binding to an enzyme by a conformational selection pathway.
    Kovermann M; Grundström C; Sauer-Eriksson AE; Sauer UH; Wolf-Watz M
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6298-6303. PubMed ID: 28559350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
    Hu L; Cai X; Dong S; Zhen Y; Hu J; Wang S; Jiang J; Huang J; Han Y; Qian Y; Yuan Y; Hu W
    J Med Chem; 2020 Jul; 63(13):6959-6978. PubMed ID: 32551649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
    Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
    J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Complex Structure of Protein AaLpxC from
    Fan S; Li D; Yan M; Feng X; Lv G; Wu G; Jin Y; Wang Y; Yang Z
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.
    Chen D; Hackbarth C; Ni ZJ; Wu C; Wang W; Jain R; He Y; Bracken K; Weidmann B; Patel DV; Trias J; White RJ; Yuan Z
    Antimicrob Agents Chemother; 2004 Jan; 48(1):250-61. PubMed ID: 14693547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligand-free and -bound structures of the binding protein (LivJ) of the Escherichia coli ABC leucine/isoleucine/valine transport system: trajectory and dynamics of the interdomain rotation and ligand specificity.
    Trakhanov S; Vyas NK; Luecke H; Kristensen DM; Ma J; Quiocho FA
    Biochemistry; 2005 May; 44(17):6597-608. PubMed ID: 15850393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors.
    Shen G; Zhu J; Simpson AM; Pei D
    Bioorg Med Chem Lett; 2008 May; 18(10):3060-3. PubMed ID: 18093832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. YqfB protein from Escherichia coli: an atypical amidohydrolase active towards N
    Stanislauskienė R; Laurynėnas A; Rutkienė R; Aučynaitė A; Tauraitė D; Meškienė R; Urbelienė N; Kaupinis A; Valius M; Kaliniene L; Meškys R
    Sci Rep; 2020 Jan; 10(1):788. PubMed ID: 31964920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.
    Fieulaine S; Desmadril M; Meinnel T; Giglione C
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):242-52. PubMed ID: 24531459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts.
    Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Desmadril M; Nhiri N; Van Dorsselaer A; Cianferani S; Jacquet E; Meinnel T; Giglione C
    Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):348-355. PubMed ID: 29101077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.